4Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J].Clin Infect Dis,2002,34:7-14.
5Kami M,Kishi Y,Hamaki T,et al.The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis:an autopsy-based retrospective study of 48 patients[J].Mycoses,2002,45:287-294.
6Rello J,Esandi ME,Diaz E,et al.The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients[J].Chest,1998,114:146-149.
7Maertens J,Theunissen K,Verbeken E,et al.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients[J].Br J Haematol,2004,126:852-860.
8Walsh TJ,Shoham S,Petraitiene R,et al.Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro,in vivo,and clinical properties of the drug-antigen interaction[J].J Clin Microbiol,2004,42:4744-4748.
9Dalle F,Charles PE,Blanc K,et al.Cryptococcus neoformans galactoxylomannan contains an epitope(s)that is cross-reactive with Aspergillus Galactomannan[J].J Clin Microbiol,2005,43:2929-2931.
10Obayashi T,Yoshida M,Mori T,et al.Plasma(1-3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes[J].Lancet,1995,345:17-20.
